MustGrow Biologics Corp. (MGRO.V)
CAD 1.24
(-3.13%)
CAD 1.24
(-3.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.71 Million | 6479.00 | 12.86 Thousand | - | - | 2000.00 |
| Cost of Revenue | 384.68 Thousand | - | - | - | - | - |
| Gross Profit | 4.32 Million | 6479.00 | 12.86 Thousand | - | - | 2000.00 |
| Operating Expenses | 4.53 Million | 5.69 Million | 3.02 Million | 3.36 Million | 1.47 Million | 1.85 Million |
| Selling, General and Administrative Expenses | 3.68 Million | 5.21 Million | 2.56 Million | 3.22 Million | 1.38 Million | 1.84 Million |
| Research and Development Expenses | 857.06 Thousand | 475.85 Thousand | 458.38 Thousand | 149.24 Thousand | 82.99 Thousand | 13.54 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4.92 Million | 5.69 Million | 3.02 Million | 3.36 Million | 1.47 Million | 1.85 Million |
| Operating Income | -210.93 Thousand | -5.55 Million | -3.01 Million | -3.36 Million | -1.47 Million | -1.85 Million |
| Interest Expense | - | 10.06 Thousand | 52.76 Thousand | 45.87 Thousand | 45.87 Thousand | 40.24 Thousand |
| Income Tax Expense | - | -25.8 Thousand | 52.76 Thousand | 45.87 Thousand | 45.87 Thousand | -161.14 Thousand |
| Earnings before Tax | -676.94 Thousand | -5.56 Million | -3.06 Million | -3.3 Million | -1.51 Million | -1.89 Million |
| Net Income | -676.94 Thousand | -5.54 Million | -3.11 Million | -3.35 Million | -1.56 Million | -1.89 Million |
| Earnings Per Share Basic | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | -0.08 |
| Earnings Per Share Diluted | -0.01 | -0.11 | -0.07 | -0.09 | -0.06 | -0.08 |
| Weighted Average Shares Outstanding | 49.89 Million | 49.01 Million | 43.73 Million | 37.31 Million | 25.29 Million | 24.98 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.89 Million | 49.01 Million | 43.73 Million | 37.31 Million | 25.29 Million | 24.98 Million |
| Gross Margin | 0.92 | 1.00 | 1.00 | - | - | 1.00 |
| EBIT Margin | -0.14 | -861.49 | -233.98 | - | - | -926.57 |
| Profit Margin | -0.14 | -855.08 | -242.18 | - | - | -946.69 |
| EBITDA | -676.94 Thousand | -5.55 Million | -3.01 Million | -3.26 Million | -1.47 Million | -1.85 Million |
| Earnings Before Tax Margin | -0.04 | -857.51 | -233.98 | - | - | -926.57 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 4.71 Million | 4.71 Million | - | - |
| Cost of Revenue | 58.12 Thousand | - | - | - | - | - |
| Gross Profit | -58.12 Thousand | - | 4.71 Million | 4.71 Million | - | - |
| Operating Expenses | 1.02 Million | 1.12 Million | 5.51 Million | 1.24 Million | 1.91 Million | 1.24 Million |
| Selling, General and Administrative Expenses | 900.54 Thousand | 817.25 Thousand | - | 810.34 Thousand | 1.55 Million | 1.01 Million |
| Research and Development Expenses | 122.39 Thousand | 307.08 Thousand | - | 186.2 Thousand | 97.29 Thousand | 230.83 Thousand |
| Other Expenses | 258.01 Thousand | - | - | - | - | - |
| Cost and Expenses | 1.02 Million | 1.12 Million | 5.51 Million | 1.24 Million | 1.91 Million | 1.24 Million |
| Operating Income | -1.02 Million | -1.12 Million | -593.39 Thousand | 3.51 Million | -1.86 Million | -1.24 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -823.05 Thousand | -43.27 Thousand | -167.89 Thousand | -43.81 Thousand | 39.58 Thousand | -122.08 Thousand |
| Earnings before Tax | -960.2 Thousand | -1.03 Million | -676.94 Thousand | 3.43 Million | -1.85 Million | -1.2 Million |
| Net Income | -960.2 Thousand | -1.03 Million | -676.94 Thousand | 3.43 Million | -1.85 Million | -1.2 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | - | 0.07 | -0.04 | -0.02 |
| Earnings Per Share Diluted | -0.02 | -0.02 | - | 0.07 | -0.04 | -0.02 |
| Weighted Average Shares Outstanding | 51.64 Million | 51.46 Million | 49.89 Million | 51.46 Million | 49.88 Million | 49.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 51.64 Million | 51.46 Million | 49.89 Million | 51.46 Million | 49.88 Million | 49.69 Million |
| Gross Margin | - | - | 1.00 | 1.00 | - | - |
| EBIT Margin | - | - | - | 0.75 | - | - |
| Profit Margin | - | - | -0.14 | 0.73 | - | - |
| EBITDA | -1.02 Million | -1.12 Million | - | 3.51 Million | -1.86 Million | -1.24 Million |
| Earnings Before Tax Margin | - | - | -0.13 | 0.75 | - | - |
ALRGR
EXPLEOSOL
SOFW
000755
7096
HUBG